NEXT

The Legal Intelligencer

Up to $1.1 Billion: Inside the Settlement Resolving Most of Philadelphia's Risperdal Cases

According to settlement records, the settlement's group expenses were $33 million, with additional costs expected to be incurred.
7 minute read

The Legal Intelligencer

Nearly Half of Philadelphia's Mass Tort Programs Are on Track to Close This Year

"Within the next several months, the court will be closing the Risperdal, Essure and Elmiron mass tort programs, as the lawyers and self-represented parties work through the remaining cases on the docket," Judge Joshua Roberts, head of the Philadelphia Court of Common Pleas Complex Litigation Center, said.
4 minute read

New Jersey Law Journal

Kirkland & Ellis Hired for Big Pharma Antitrust Suit

A 2020 verdict allowed Teva and other companies to produce generic versions of Vascepa. But Teva allegedly had to scale back its launch because of an inability to obtain the key ingredient, the suit said.
4 minute read

Law.com

Opioid Judge Rejects DQ Motion, But Cautions Motley Rice: 'The Court Frowns'

U.S. District Judge Dan Polster on Monday declined to disqualify Motley Rice from dozens of opioid cases, but said he was "very uncomfortable" with its government client arrangements.
5 minute read

Law.com

Another Defendant Says Motley Rice Should Be Disqualified From Opioid Litigation

Express Scripts Inc., a pharmacy benefit manager facing upcoming bellwether trials over the opioid crisis, filed a March 13 brief referencing a subpoena that Motley Rice member Linda Singer sent to the company on behalf of the city of Chicago.
4 minute read

Law.com

Social Media Ads Inject New Angle in Ozempic Cases: 'It's Going to Be a Huge Focus'

The proliferation of advertising on social media for Ozempic and related drugs will be a key part of the lawsuits against Novo Nordisk and Eli Lilly.
6 minute read

The Legal Intelligencer

Don't Be Cranky and Don't Cause Delays: Judge Pushes for Efficiency in Ozempic MDL

"What I want is to avoid asking for continuances and asking for delay and asking for new dates. Just pick your poison and stick with it," Pratter told the approximately 70 people gathered in her courtroom Thursday.
4 minute read

Corporate Counsel

After Honing Skills at Pharma Heavyweight, Attorney Takes First GC Post

"I love the fast pace and urgency," said Andy Rittenberg, the newly appointed general counsel of Coherus BioSciences. "We have a lot on our plates and accomplish a lot with a small team."
2 minute read

Corporate Counsel

Weight-Loss-Drug Craze Pumps Up Pay for Lilly GC

Anat Hakim joined Lilly in 2020, just before the company's stock began a long ascent that has more than quadrupled its value—pushing the company's market capitalization past Tesla's.
2 minute read

The Legal Intelligencer

Phila. Mass Tort Over Janssen Bladder Drug Winds Down Without Bellwether Trial

The first trial in the mass tort had been scheduled to begin Monday, but most of the program's cases were resolved through confidential settlements in the last six months, according to Kline & Specter partner Tobi Millrood, who serves as plaintiffs liaison counsel in the matter.
3 minute read

Resources

  • Yearly Roundup: Strategic Insights for Law Firm Decision Making

    Brought to you by CARET Legal

    Download Now

  • Lex Machina Contracts: Commercial Litigation Report 2024

    Brought to you by LexisNexis®

    Download Now

  • White Collar Investigation Practice: Global Expertise in Complex Investigations

    Brought to you by HaystackID

    Download Now

  • Criminal Division's Evaluation of Corporate Compliance Programs: September 2024 Updates Review

    Brought to you by NAVEX Global

    Download Now